Get started
Author

Christine Windemuth-Kieselbach

Observed names: C Windemuth-Kieselbach, C. Windemuth-Kieselbach, Windemuth-Kieselbach, Christine
OpenAlex ID: A5004684398
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial
2020 · Lisa Zimmer, Elisabeth Livingstone, et al. · The Lancet · 251
Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center
2007 · Christian P. Jacob, Jasmin Romanos, et al. · European Archives of Psychiatry and Clinical Neuroscience · 246
Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns—Results of a non-interventional study of the DeCOG
2018 · Uwe Hillen, Ulrike Leiter, et al. · European Journal of Cancer · 127
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial
2022 · Elisabeth Livingstone, Lisa Zimmer, et al. · The Lancet · 118
Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12
2008 · M Romanos, C Freitag, et al. · Molecular Psychiatry · 110
Association and linkage of allelic variants of the dopamine transporter gene in ADHD
2002 · S Friedel, K Saar, et al. · Molecular Psychiatry · 81
Prospective evaluation of follow-up in melanoma patients in Germany – Results of a multicentre and longitudinal study
2015 · E. Livingstone, C. Krajewski, et al. · European Journal of Cancer · 60
A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up
2011 · Elisabeth Livingstone, Christine Windemuth-Kieselbach, et al. · European Journal of Cancer · 60
Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer
2013 · Joachim Rom, Sarah Bechstein, et al. · Anti-Cancer Drugs · 39
A gene–environment investigation on personality traits in two independent clinical sets of adult patients with personality disorder and attention deficit/hyperactive disorder
2009 · Christian P. Jacob, Thuy Trang Nguyen, et al. · European Archives of Psychiatry and Clinical Neuroscience · 37
Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAFV600 mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trial
2021 · Lisa Zimmer, Elisabeth Livingstone, et al. · European Journal of Cancer · 27
Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC
2010 · Alexandra D Jensen, Anna Nikoghosyan, et al. · BMC Cancer · 20
PDF
Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12)
2011 · Alexandra D Jensen, Anna V Nikoghosyan, et al. · BMC Cancer · 18
PDF
Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial
2023 · E. Livingstone, H. Gogas, et al. · European Journal of Cancer · 15
Gene expression profiling at birth characterizing the preterm infant with early onset infection
2016 · Anne Hilgendorff, Anita Windhorst, et al. · Journal of Molecular Medicine · 12
PDF
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial
2025 · Jürgen C Becker, Anja H Gesierich, et al. · British Journal of Dermatology · 9
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study
2022 · Ralf-Dieter Hofheinz, Sandro Anchisi, et al. · Cancers · 8
PDF
Assessment of Quality of Life in Postmenopausal Women with Early Breast Cancer Participating in the PACT Trial: The Impact of Additional Patient Information Material Packages and Patient Compliance
2019 · Christian Jackisch, Rolf Kreienberg, et al. · Breast Care · 8
Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry
2020 · Karin Hohloch, Christine Windemuth-Kieselbach, et al. · Annals of Hematology · 7
PDF
Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer
2013 · Nadia Harbeck, Maria Blettner, et al. · Breast Care · 7
PDF
PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study
2018 · Peter Hammerer, Salah-Eddin Al-Batran, et al. · World Journal of Urology · 6
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study
2014 · E. Livingstone, T.K. Eigentler, et al. · British Journal of Dermatology · 6
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints
2024 · Valentina O. Puntmann, Dietrich Beitzke, et al. · Journal of Cardiovascular Magnetic Resonance · 4
Radioimmunotherapy for Mantle Cell Lymphoma: 5-Year Follow-up of 90 Patients from the International RIT-Registry
2019 · Karin Hohloch, Christine Windemuth-Kieselbach, et al. · Blood · 3
P5-17-05: 24 Months Follow-Up Results from PACT (Patient's Anastrozole Compliance to Therapy Programme), a Non-Interventional Study Evaluating the Influence of a Standardized Information Service on Compliance in Postmenopausal Women with Early Breast Cancer.
2011 · H-J Lueck, P Hadji, et al. · Cancer Research · 3
Works count: 36
Citation count: 1,402
H-index: 15
I10-index: 16
Year
Topic
Type